In 2023, Jason Kelly earned $262.50K in total compensation at Ginkgo Bioworks, primarily from $250.00K salary. Most recently sold 200,000 shares in Jan 2024. Currently holds stock worth $36.03M. Has donated $34.69K in stock to charitable causes. Has led Ginkgo Bioworks for over 17 years.
Compensation History
Annual executive compensation data for Jason Kelly, including salary, bonuses, and stock awards.
Year
2023
Total Compensation
$262.50K
Salary
$250.00K
Bonus
$0.00
Other
$12.50K
Salary
$250.00KBoard Justification
Ginkgo's compensation programs are designed to attract, retain, and engage talent, emphasizing performance and contribution to long-term success.
Bonus
$0.00Board Justification
The Company does not currently have an annual cash bonus or incentive program for any of its employees, including its named executive officers.
Other Compensation
$12.50KBoard Justification
This amount represents employer non-elective contributions under Ginkgo’s 401(k) plan in 2023.
Restricted Stock
Board Justification
Dr. Kelly did not receive any stock grants in 2023 as he had previously received equity awards in 2021, which are not included in this year's compensation.
Performance Metrics
The compensation of Dr. Kelly is not tied to specific performance metrics for 2023, as the Company does not currently have an annual cash bonus or incentive program.
Jason Kelly
Founder and CEO of Ginkgo Bioworks
Education
Ph.D. in Biological Engineering and B.S. in Chemical Engineering and Biology from MIT
Field of Expertise
Healthcare & Life Sciences - Biotechnology
Sector of Economy
Healthcare
Born
January 1, 1982 - 43 years ago
CEO of Ginkgo Bioworks for
17 years 11 months (Jan 2008 - Present)
Previous Experience
Founder of Ginkgo Bioworks
Holdings
Track Jason Kelly's stock holdings and portfolio value over time.
Total Stock Sold
$44.11M
$44.11M
566,528.175 DNA shares
What if they kept their stock?
If Jason Kelly didn't sell their stock, today they would have:
Extra DNA566,528.175 shares worth $5.24M.
This is -88.12% and $38.87M less than what they got when they sold the stock.
Charitable Transactions
3,750 shares
DNA
Recent Charitable Transactions
150,000 shares
DNA
Dec 6, 2021
Charity
Insider Trading
Jason Kelly's recent stock transactions, purchases, and sales filed with the SEC.
$309.90K
DNA at $1.55/share
Jan 3, 2024
Sale
$353.10K
DNA at $1.77/share
Dec 20, 2023
Sale
$296.60K
DNA at $1.48/share
Dec 13, 2023
Sale
$263.60K
DNA at $1.32/share
Dec 6, 2023
Sale
$280.50K
DNA at $1.40/share
Nov 29, 2023
Sale
$281.70K
DNA at $1.41/share
Nov 22, 2023
Sale
$299.40K
DNA at $1.50/share
Nov 15, 2023
Sale
$279.30K
DNA at $1.40/share
Nov 8, 2023
Sale
$285.80K
DNA at $1.43/share
Nov 1, 2023
Sale
$293.50K
DNA at $1.47/share
Oct 25, 2023
Sale
Rivals
Compare Jason Kelly with competitor CEOs and industry peers.